The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/21787
StudyName: Eligibility Essential Hypertension NCT00872586
Date of export from the portal: 02.07.2020
Date of Upload / last change: 30.04.2017
License: Creative Commons BY 4.0

----

Description: 
Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00872586
